Nature Reviews Drug Discovery



Harnessing venture philanthropy to accelerate medical progress ()

>> Read More

Novel targets for itch treatment ()

>> Read More

Clinical promise of next-generation complement therapeutics ()

>> Read More

Transition probabilities for clinical trials: investigating individual diseases ()

>> Read More

Microbiome therapeutics go small molecule ()

>> Read More

FDA new drug approvals in Q2 2019 ()

>> Read More

Anti-CD3 antibody charts out a type 1 diabetes comeback ()

>> Read More

Building on bispecifics ()

>> Read More